Jeremy David Davies is the Founder and Chief Executive Officer of DEIRA LIMITED. He has spent more than fifteen years advising pharmaceutical organizations on scientific strategy, product development, and healthcare innovation.
Throughout his career, Jeremy has contributed to numerous national and international scientific advisory initiatives and has developed extensive expertise in pharmaceutical research, manufacturing strategy, and healthcare investment.
In July 2014, he founded Chronic Labs (IOM) Limited with the objective of building a specialized pharmaceutical enterprise focused on the development and supply of Active Pharmaceutical Ingredients for neurological and cognitive disorders. As the company expanded its capabilities, international partnerships, and strategic objectives, the business was rebranded as DEIRA LIMITED in April 2021, reflecting its broader vision and long-term commitment to pharmaceutical innovation and global healthcare solutions.
Today, Jeremy continues to lead the company’s growth strategy while maintaining a strong focus on scientific excellence, operational quality, and regulatory compliance.